Ranitidine

Product NDC
65162-664
11-digit product format
651620664
Labeler code
65162
Product ID
65162-664_022a0dc5-868f-4c73-a9f9-a6cd4c7c5331
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ranitidine
Dosage form
SOLUTION
Route
ORAL
Labeler
Amneal Pharmaceuticals LLC
Application
ANDA078312
Marketing category
ANDA
Marketing start
2010-03-12
Marketing end
0000-00-00
Substance
RANITIDINE HYDROCHLORIDE
Active strength
15 mg/mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7f54af34-be54-4c3c-894f-78df6452d747Product name320190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850Product name520190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7bProduct name120180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228Product name120160720

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
65162-664-902024-10-30C16284748780-11030e365-56fd-111a-e063-dadaa90a10e28f0bb213-6342-4fea-a080-24def590d1ba
65162-664-902024-01-30C16284748780-11030e365-56fd-111a-e063-dadaa90a10e28f0bb213-6342-4fea-a080-24def590d1ba

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65162-664-90ML - Milliliter65162-664097cb5e3-5c93-4344-a4f7-dff537a6448312012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHMRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
RANITIDINEACTIVE MOIETY884KT10YB7RANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV8RANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WORANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
PEPPERMINTINACTIVE INGREDIENTV95R5KMY2BRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3RANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
SODIUM PHOSPHATE, DIBASICINACTIVE INGREDIENTGR686LBA74RANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
SODIUM PHOSPHATE, MONOBASICINACTIVE INGREDIENT3980JIH2SWRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
SORBITOLINACTIVE INGREDIENT506T60A25RRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
WATERINACTIVE INGREDIENT059QF0KO0RRANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]4
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHMRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
RANITIDINEACTIVE MOIETY884KT10YB7RANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV8RANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WORANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
PEPPERMINTINACTIVE INGREDIENTV95R5KMY2BRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3RANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SODIUM PHOSPHATE, DIBASICINACTIVE INGREDIENTGR686LBA74RANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SODIUM PHOSPHATE, MONOBASICINACTIVE INGREDIENT3980JIH2SWRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SORBITOLINACTIVE INGREDIENT506T60A25RRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
WATERINACTIVE INGREDIENT059QF0KO0RRANITIDINE SOLUTION [ATLANTIC BIOLOGICALS CORPS]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65162-664RANITIDINE SOLUTION [AMNEAL PHARMACEUTICALS LLC]10Legacy NDC20241031_8f0bb213-6342-4fea-a080-24def590d1ba.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
705610ranitidine 15 MG/ML Oral SolutionSCD804ba82f-aaf6-46ec-8765-341c5ee2942a2
705610ranitidine 15 MG (as ranitidine HCl 16.8 MG) per 1 ML Oral SolutionSY804ba82f-aaf6-46ec-8765-341c5ee2942a2
705610ranitidine 75 MG per 5 ML SyrupSY804ba82f-aaf6-46ec-8765-341c5ee2942a2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
65162-664-9065162066490473 mL in 1 BOTTLE (65162-664-90) 473 ml2010-03-120000-00-00NoNoCurrent